Glucocorticoid-mediated_JJ
repression_NN
of_IN
cytokine_NN
gene_NN
transcription_NN
in_IN
human_JJ
arteritis-SCID_NN
chimeras_NNS
._.

Giant_JJ
cell_NN
arteritis_NN
-LRB-_-LRB-
GCA_NN
-RRB-_-RRB-
is_VBZ
a_DT
vasculitic_JJ
syndrome_NN
that_WDT
preferentially_RB
affects_VBZ
medium_NN
and_CC
large-sized_JJ
arteries_NNS
._.

Glucocorticoid_NN
therapy_NN
resolves_VBZ
clinical_JJ
symptoms_NNS
within_IN
hours_NNS
to_TO
days_NNS
,_,
but_CC
therapy_NN
has_VBZ
to_TO
be_VB
continued_VBN
over_IN
several_JJ
years_NNS
to_TO
prevent_VB
disease_NN
relapses_NNS
._.

It_PRP
is_VBZ
not_RB
known_VBN
whether_IN
and_CC
how_WRB
glucocorticoids_NNS
affect_VBP
the_DT
function_NN
of_IN
the_DT
inflammatory_JJ
infiltrate_NN
or_CC
why_WRB
the_DT
disease_NN
persists_VBZ
subclinically_RB
despite_IN
chronic_JJ
treatment_NN
._.

GCA_NN
is_VBZ
self-sustained_JJ
in_IN
temporal_JJ
arteries_NNS
engrafted_VBN
into_IN
SCID_NN
mice_NNS
,_,
providing_VBG
a_DT
model_NN
in_IN
which_WDT
the_DT
mechanisms_NNS
of_IN
action_NN
and_CC
limitations_NNS
of_IN
glucocorticoid_NN
therapy_NN
can_MD
be_VB
examined_VBN
in_FW
vivo_FW
._.

Administration_NN
of_IN
dexamethasone_NN
to_TO
temporal_JJ
artery-SCID_NN
chimeras_NNS
for_IN
1_CD
wk_NN
induced_VBD
a_DT
partial_JJ
suppression_NN
of_IN
T_NN
cell_NN
and_CC
macrophage_NN
function_NN
as_IN
indicated_VBD
by_IN
the_DT
reduced_VBN
tissue_NN
concentrations_NNS
of_IN
IL-2_NN
,_,
IL-1beta_NN
,_,
and_CC
IL-6_NN
mRNA_NN
,_,
and_CC
by_IN
the_DT
diminished_VBN
expression_NN
of_IN
inducible_JJ
NO_NN
synthase_NN
._.

In_IN
contrast_NN
,_,
synthesis_NN
of_IN
IFN-gamma_NN
mRNA_NN
was_VBD
only_RB
slightly_RB
decreased_VBN
,_,
and_CC
expression_NN
of_IN
TGF-beta1_NN
was_VBD
unaffected_JJ
._.

These_DT
findings_NNS
correlated_VBD
with_IN
activation_NN
of_IN
the_DT
IkappaBalpha_NN
gene_NN
and_CC
blockade_NN
of_IN
the_DT
nuclear_JJ
translocation_NN
of_IN
NFkappaB_NN
in_IN
the_DT
xenotransplanted_VBN
tissue_NN
._.

Dose-response_JJ
experiments_NNS
suggested_VBD
that_IN
steroid_NN
doses_NNS
currently_RB
used_VBN
in_IN
clinical_JJ
medicine_NN
are_VBP
suboptimal_JJ
in_IN
repressing_VBG
NFkappaB-mediated_JJ
cytokine_NN
production_NN
in_IN
the_DT
inflammatory_JJ
lesions_NNS
._.

Chronic_JJ
steroid_NN
therapy_NN
was_VBD
able_JJ
to_TO
deplete_VB
the_DT
T_NN
cell_NN
products_NNS
IL-2_NN
and_CC
IFN-gamma_NN
,_,
whereas_IN
the_DT
activation_NN
of_IN
tissue-infiltrating_JJ
macrophages_NNS
was_VBD
only_RB
partially_RB
affected_VBN
._.

IL-1beta_NN
transcription_NN
was_VBD
abrogated_VBN
;_:
in_IN
contrast_NN
,_,
TGF-beta1_NN
mRNA_NN
synthesis_NN
was_VBD
steroid_NN
resistant_JJ
._.

The_DT
persistence_NN
of_IN
TGF-beta1-transcribing_JJ
macrophages_NNS
,_,
despite_IN
paralysis_NN
of_IN
T_NN
cell_NN
function_NN
,_,
may_MD
provide_VB
an_DT
explanation_NN
for_IN
the_DT
chronicity_NN
of_IN
the_DT
disease_NN
,_,
and_CC
may_MD
identify_VB
a_DT
novel_JJ
therapeutic_JJ
target_NN
in_IN
this_DT
inflammatory_JJ
vasculopathy_NN
._.

